🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase II, open-label, single dose level study of PRL3-ZUMAB monot...
Status
Completed
Location
National Cancer Center Singapore
Start Date
2019-09-03
Trial ID
NCT04118114
Treatments Being Tested
This is a Multi-Center, Phase II/III, open-label, single dose level (6 mg/k...
Status
Recruiting
Location
Hosp. Universiti Sains Malaysia (HUSM), Kelantan
Start Date
2023-01-09
Trial ID
NCT07290088
Treatments Being Tested
This study is carried out to test the safety of a study drug called PRL3-ZU...
Status
Active Not Recruiting
Location
National University Hospital
Start Date
2017-02-20
Trial ID
NCT03191682
Treatments Being Tested
This is a multi-center, Phase 2, open-label, single dose level study of PRL...
Status
Active Not Recruiting
Location
HonorHealth Research
Start Date
2020-12-12
Trial ID
NCT04452955
Treatments Being Tested
Study Design This is a Single-center, Phase I/II placebo-controlled study t...
Status
Recruiting
Location
NUHS Department of Ophthalmology
Start Date
2025-10-11
Trial ID
NCT07547228
Treatments Being Tested
This is a multicenter, Phase II, open-label, single-dose-level (6 mg/kg) st...
Status
Active Not Recruiting
Location
Hangzhou Cancer Hospital
Start Date
2021-08-30
Trial ID
NCT07541001
Treatments Being Tested